Offer - Urjas Oil for just ₹ 1
Nebisartan is an allopathic medicine The correct dosage of Nebisartan depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nebisartan is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Nebisartan safe for pregnant women?
Nebisartan shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebisartan safe during breastfeeding?
Nebisartan should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nebisartan on the Kidneys?
Nebisartan rarely affects the kidneys.
What is the effect of Nebisartan on the Liver?
Nebisartan is rarely harmful for the liver.
What is the effect of Nebisartan on the Heart?
Very few cases of side effects of Nebisartan on the heart have been reported.
Nebisartan should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nebisartan unless your doctor advises you to do so -
Is this Nebisartan habit forming or addictive?
Forming a habit of Nebisartan has not been reported.
Interaction between Food and Nebisartan
When consumed with certain foods, Nebisartan may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nebisartan
Taking Nebisartan with alcohol can have severely harmful effects on your health.
Nebisartan is the brand name for telmisartan. It belongs to a group of medications known as angiotensin II receptor blockers. It is available in the form of tablets. Nebisartan is used to treat hypertension. It is also used to decrease cardiovascular risk in patients who cannot take ACE (angiotensin-converting enzyme) inhibitors.
Nebisartan can be taken as long as it is prescribed by your doctor. You must not discontinue taking it even when you start feeling well. In addition, you must not take it more frequently as that can have adverse effects. Follow the recommendations of your doctor completely.
Yes, Nebisartan causes hyponatremia (low level of sodium in the blood). Treatment with telmisartan might call for a regular blood monitoring for checking sodium levels.
Nebisartan contains telmisartan which is an antihypertensive drug that works by preventing a chemical (angiotensin II) to bind with a receptor. This causes relaxation of blood vessels, it also prevents the synthesis and release of aldosterone (a hormone whose hyperactivity results in high blood pressure). In this way Nebisartan decreases the blood pressure.
Yes, it is safe to take Nebisartan as long as it is prescribed by your doctor. However, in some people, it may cause some side effects like back pain, sinusitis, and diaarhea.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
